After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, CYTK falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Cytokinetics Inc is $4.32B. A total of 1.16 million shares were traded on the day, compared to an average of 1.59M shares.
In the most recent transaction, Malik Fady Ibraham sold 2,000 shares of CYTK for 36.34 per share on Aug 05 ’25. After the transaction, the EVP Research & Development now owns 140,610 company shares. In a previous transaction on Jul 29 ’25, Blum Robert I sold 5,000 shares at 36.45 per share. CYTK shares that President & CEO owns now total 388,108.
Among the insiders who sold shares, Malik Fady Ibraham disposed of 2,000 shares on Jul 22 ’25 at a per-share price of $37.47. This resulted in the EVP Research & Development holding 140,610 shares of CYTK after the transaction. In another insider transaction, Blum Robert I sold 5,000 shares at $38.15 per share on Jul 14 ’25. Company shares held by the President & CEO now total 393,108.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CYTK has a high of $59.39 and a low of $29.31.
As of this writing, CYTK has an earnings estimate of -$1.36 per share for the current quarter. EPS was calculated based on a consensus of 17.0 estimates, with a high estimate of -$0.35 per share and a lower estimate of -$1.6.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CYTK’s latest balance sheet shows that the firm has $471.64M in Cash & Short Term Investments as of fiscal 2021. There were $269.93M in debt and $71.86M in liabilities at the time. Its Book Value Per Share was -$2.23, while its Total Shareholder’s Equity was $243.86M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
